Tech Company Financing Transactions
Pendulum Therapeutics Funding Round
Pendulum Therapeutics, based in San Francisco, secured $54 million from Meritech Capital Partners, Khosla Ventures and Sequoia Capital.
Transaction Overview
Company Name
Announced On
4/8/2021
Transaction Type
Venture Equity
Amount
$54,000,000
Round
Series C
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
933 20th St.
San Francisco, CA 94107
USA
San Francisco, CA 94107
USA
Phone
Website
Email Address
Overview
Founded and based in San Francisco, we're a team of scientists, doctors and innovators. But more than that, we're a team with passion and purpose. Driven by finding improvements to managing chronic illnesses through the microbiome, Pendulum is empowering people with groundbreaking products and tools to achieve long-term health.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Colleen Cutcliffe
Chief Medical Officer
Orville Kolterman
Chief Scientific Officer
John Eid
Chief Technical Officer
James Bullard
VP - Bus. Development
David Raksin
VP - Regulatory Affairs
Achal Deo
Browse more venture capital transactions:
Prev: 4/8/2021: Firefly Health venture capital transaction
Next: 4/9/2021: Spot.xyz venture capital transaction
Share this article
News on VC Transactions
We do our best to record every notable VC transaction. VC investment data records on this site are sourced from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs